Drug Trial Radar · NCT04391569
Randomized Therapy In Status Epilepticus
Last checked: Nov 19, 2026Latest source record: May 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Dec 9, 2020
Primary completion
Mar 30, 2024
Study completion Apr 28, 2024
Sponsor
- Lead sponsor
- Marinus PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- May 18, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluated the effectiveness and safety of an investigational product (IP), intravenous (IV) ganaxolone, to treat participants with status epilepticus (SE).
Conditions
- Status Epilepticus
Interventions
GanaxoloneDrug
Ganaxolone will be administered.
PlaceboDrug
Placebo will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With SE Cessation Within 30 Minutes of Investigational Product (IP) Initiation Without Medications for the Acute Treatment of SETime frame: Up to 30 minutes
- Percentage of Participants With no Progression to Intravenous (IV) Anesthesia for 36 Hours Following Investigational Product (IP) InitiationTime frame: Up to 36 hours after IP initiation
- Number of Participants With Treatment Emergent Adverse EventsTime frame: Up to 4 weeks after IP initiation
Locations
74 sites in 3 countries. Site status is shown where the registry gives one.
Marinus Research Site
Birmingham, Alabama
Marinus Research Site
Phoenix, Arizona
Marinus Research Site
Little Rock, Arkansas
Marinus Research Site
Downey, California
Marinus Research Site
La Jolla, California
Marinus Research Site
Orange, California
Marinus Research Site
Sacramento, California
Marinus Research Site
Aurora, Colorado
Marinus Research Site
Denver, Colorado
Marinus Research Site
New Haven, Connecticut
Marinus Research Site
Gainesville, Florida
Marinus Research Site #1
Miami, Florida
Marinus Research Site
Miami, Florida
Marinus Research Site
Miami, Florida
Marinus Research Site
Port Saint Lucie, Florida
Marinus Research Site
Tampa, Florida
Marinus Research Site
Chicago, Illinois
Marinus Research Site
Chicago, Illinois
Marinus Research Site
Urbana, Illinois
Marinus Research Site
Louisville, Kentucky
Marinus Research Site
New Orleans, Louisiana
Marinus Research Site
Shreveport, Louisiana
Marinus Research Site #1
Baltimore, Maryland
Marinus Research Site
Baltimore, Maryland
Marinus Research Site
Baltimore, Maryland
Marinus Research Site
Boston, Massachusetts
Marinus Research Site
Boston, Massachusetts
Marinus Research Site
Boston, Massachusetts
Marinus Research Site
Boston, Massachusetts
Marinus Research Site
Boston, Massachusetts
Marinus Research Site
Worcester, Massachusetts
Marinus Research Site
Ann Arbor, Michigan
Marinus Research Site
Grand Rapids, Michigan
Marinus Research Site
Columbia, Missouri
Marinus Research Site
St Louis, Missouri
Marinus Research Site
New Brunswick, New Jersey
Marinus Research Site
Albuquerque, New Mexico
Marinus Research Site
Albany, New York
Marinus Research Site
Brooklyn, New York
Marinus Research Site
New York, New York
Showing 40 of 74 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.